Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role

By AHRMM

Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.

Related Resources

Advisory
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.
Issue Brief
This learning lab covers alarm safety management in the health care supply chain field.
Advisory
An overview of the Centers for Medicare & Medicaid Services' three final rules for calendar year 2011 the outpatient prospective payment
Advisory
The Patient Protection and Affordable Care Act of 2010 (ACA) requires the Secretary of Health and Human Services to establish a VBP program t
Advisory
Hospital Compare: CMS Suspends Display of Hospital-Acquired Conditions Data
Advisory
New Guidance on Humidity Levels in the Operating Room